AB133-ASA1-AA2, s. 2359tw 9Section 2359tw. 230.046 (5) (intro.) of the statutes is amended to read:
AB133-ASA1-AA2,411,1210 230.046 (5) Initiation of programs. (intro.) Unless otherwise empowered by
11law, any agency desiring to initiate a training program under sub. (3) shall certify
12to the secretary
ensure that:
AB133-ASA1-AA2, s. 2359uc 13Section 2359uc. 230.046 (10) of the statutes is repealed and recreated to read:
AB133-ASA1-AA2,411,1514 230.046 (10) Department functions. The department may do all of the
15following:
AB133-ASA1-AA2,411,1716 (a) Conduct off-the-job employe development and training programs relating
17to functions under this chapter or subch. V of ch. 111.
AB133-ASA1-AA2,411,1918 (b) Charge fees to state agencies whose employes participate in employe
19development and training programs under this subsection.
AB133-ASA1-AA2, s. 2359uh 20Section 2359uh. 230.046 (11) of the statutes is repealed.".
AB133-ASA1-AA2,411,21 21906. Page 1198, line 14: after that line insert:
AB133-ASA1-AA2,411,22 22" Section 2362p. 230.08 (2) (pm) of the statutes is amended to read:
AB133-ASA1-AA2,411,2323 230.08 (2) (pm) The All employes of the state fair park director board.".
AB133-ASA1-AA2,411,24 24907. Page 1201, line 1: delete lines 1 to 5.
AB133-ASA1-AA2,412,1
1908. Page 1205, line 3: after that line insert:
AB133-ASA1-AA2,412,2 2" Section 2376c. 234.64 of the statutes is created to read:
AB133-ASA1-AA2,412,3 3234.64 Biotechnology development finance company. (1) In this section:
AB133-ASA1-AA2,412,44 (a) "Biotechnology" means technology related to life sciences.
AB133-ASA1-AA2,412,55 (b) "Capital participation instrument" means all of the following:
AB133-ASA1-AA2,412,66 1. Any of the following or an option or other right to acquire any of the following:
AB133-ASA1-AA2,412,77 a. Common or preferred capital stock.
AB133-ASA1-AA2,412,88 b. Convertible securities.
AB133-ASA1-AA2,412,99 c. Evidences of long-term or short-term indebtedness.
AB133-ASA1-AA2,412,1010 d. Warrants.
AB133-ASA1-AA2,412,1111 e. Subscriptions.
AB133-ASA1-AA2,412,1212 f. Partnership or membership interests.
AB133-ASA1-AA2,412,1413 2. Royalties or other lawful derivations of a capital participation instrument
14listed under subd. 1.
AB133-ASA1-AA2,412,2115 (c) "Cost of a project" means costs associated with the design, planning and
16implementation of a project that, in accordance with sound business and financial
17practices, are appropriate charges to the project. The costs may include the costs of
18planning and design, options to buy land, feasibility or other studies, equipment,
19seed money, construction, working capital and any other costs determined by the
20biotechnology development finance company to be necessary to the purposes of this
21section.
AB133-ASA1-AA2,412,2322 (d) "Project" means commercial, industrial or other economic activity that is
23undertaken by a biotechnology company in this state.
AB133-ASA1-AA2,413,7
1(2) (a) The authority may organize and maintain a biotechnology development
2finance company as a nonstock, nonprofit corporation under ch. 181 for the exclusive
3purpose of investing in new or existing biotechnology companies in this state. If the
4authority organizes a biotechnology development finance company, the authority
5shall transfer all moneys received by the authority in the transfer under 1999
6Wisconsin Act .... (this act), section 9210 (2e), to the company for start-up capital and
7for reasonable administrative expenses of the company.
AB133-ASA1-AA2,413,118 (b) Subject to par. (c), the biotechnology development finance company may
9purchase a capital participation instrument of a project. The biotechnology
10development finance company shall ensure that all of the following apply with
11respect to a project before any investment is made in the project:
AB133-ASA1-AA2,413,1312 1. The biotechnology company has certified that the project plans conform to
13all applicable environmental, zoning, building, planning or sanitation laws.
AB133-ASA1-AA2,413,1514 2. There is a reasonable expectation that the biotechnology company will be
15successful.
AB133-ASA1-AA2,413,1616 3. Private industry has not provided sufficient capital required for the project.
AB133-ASA1-AA2,413,2017 4. The investment is necessary to the successful completion of the proposed
18project because other investment in the project is unavailable in the traditional
19capital markets, or because capital has been offered on terms that would preclude
20the success of the project.
AB133-ASA1-AA2,413,2421 5. Provision has been made by contract for adequate reporting of financial data
22by the project to the biotechnology development finance company. Those provisions
23may include a requirement for an annual or other periodic audit of the project's
24financial records.
AB133-ASA1-AA2,414,2
16. The proceeds of the purchase will be used solely in connection with the costs
2of the project.
AB133-ASA1-AA2,414,33 7. The biotechnology company is able to manage its project responsibilities.
AB133-ASA1-AA2,414,64 (c) 1. The biotechnology development finance company may not own more than
549% of the voting stock or other interest in any enterprise as a result of a purchase
6under par. (b).
AB133-ASA1-AA2,414,87 2. The total investment by the biotechnology development finance company in
8any one biotechnology company may not exceed $200,000.
AB133-ASA1-AA2,414,109 (d) The findings made by the biotechnology development finance company with
10respect to whether a project meets the conditions under par. (b) 1. to 7. are conclusive.
AB133-ASA1-AA2,414,19 11(3) The authority shall enter into a contract with the biotechnology
12development finance company. The contract shall provide that the authority may
13make use of the services of the biotechnology development finance company and that
14the authority shall advise, assist and provide administrative services to the
15biotechnology development finance company. The authority shall determine the
16type and scope of any administrative services provided by the authority to the
17biotechnology development finance company. The authority may assign employes or
18contract with private or state agencies to perform the administrative services. The
19biotechnology development finance company may not engage in political activities.
AB133-ASA1-AA2,414,21 20(4) (a) The board of directors of the biotechnology development finance
21company shall consist of all of the following members:
AB133-ASA1-AA2,414,2222 1. The executive director of the authority, or his or her designee.
AB133-ASA1-AA2,414,2323 2. The secretary of commerce, or his or her designee.
AB133-ASA1-AA2,414,2424 3. The secretary of administration, or his or her designee.
AB133-ASA1-AA2,414,2525 4. The executive director of the investment board, or his or her designee.
AB133-ASA1-AA2,415,1
15. The president of the University of Wisconsin System, or his or her designee.
AB133-ASA1-AA2,415,22 6. The president of Forward Wisconsin, Inc., or his or her designee.
AB133-ASA1-AA2,415,33 7. A representative of the state's biotechnology research community.
AB133-ASA1-AA2,415,44 8. A representative of the state's biotechnology industry.
AB133-ASA1-AA2,415,55 9. A representative of the state's venture capital industry.
AB133-ASA1-AA2,415,96 (b) The members under par. (a) 7. to 9. shall serve 5-year terms and the initial
7members under par. (a) 7. to 9. shall be appointed by the governor. The biotechnology
8development finance company, in its bylaws, shall specify the method for electing
9new members under par. (a) 7. to 9. and for filling vacancies.
AB133-ASA1-AA2,415,12 10(5) Annually, the biotechnology development finance company shall provide a
11report on its activities to the appropriate standing committees of each house of the
12legislature in the manner provided under s. 13.172 (3) and to the governor.
AB133-ASA1-AA2,415,19 13(6) The assets transferred to, and the assets and liabilities of, the biotechnology
14development finance company shall be separate from all other assets and liabilities
15of the state, of all political subdivisions of the state and of the authority. Neither the
16state, any political subdivision of the state nor the authority guarantees any
17obligation of or has any obligation to the biotechnology development finance
18company. Neither the state, any political subdivision of the state nor the authority
19is liable for any debt or liability of the biotechnology development finance company.".
AB133-ASA1-AA2,415,21 20909. Page 1208, line 5: delete the material beginning with that line and
21ending with page 1209, line 4.
AB133-ASA1-AA2,415,22 22910. Page 1209, line 13: delete lines 13 to 19.
AB133-ASA1-AA2,415,23 23911. Page 1210, line 11: after that line insert:
AB133-ASA1-AA2,416,2
1" Section 2400em. 250.01 (4) (a) 4. of the statutes is repealed and recreated to
2read:
AB133-ASA1-AA2,416,43 250.01 (4) (a) 4. A multiple municipal local health department established
4under s. 251.02 (3m).".
AB133-ASA1-AA2,416,5 5912. Page 1211, line 9: delete "$3,500,000" and substitute "$1,750,000".
AB133-ASA1-AA2,416,6 6913. Page 1211, line 9: delete "$4,000,000" and substitute "$2,000,000".
AB133-ASA1-AA2,416,7 7914. Page 1211, line 18: after that line insert:
AB133-ASA1-AA2,416,8 8" Section 2400qc. 251.02 (1) of the statutes is amended to read:
AB133-ASA1-AA2,416,159 251.02 (1) In counties with a population of less than 500,000, the county board
10shall establish a county health department that meets the requirements of this
11chapter. The county health department shall serve all areas of the county that are
12not served by a city health department that was established prior to January 1, 1994,
13or by a town or village multiple municipal local health department established under
14sub. (3m). No city health department may be established after that date January 1,
151994, but a city-county health department may be established after that date.
AB133-ASA1-AA2, s. 2400qd 16Section 2400qd. 251.02 (3m) of the statutes is repealed and recreated to read:
AB133-ASA1-AA2,416,2317 251.02 (3m) If a county has a population of at least 100,000 but less than
18500,000 and the county board of that county has, by July 1, 1985, abolished a county
19health commission or committee established under s. 141.10, 1991 stats., the
20governing body of a city, village or town in that county may, in concert with the
21governing body of another city, village or town in that county, establish a multiple
22municipal local health department and elect a local health officer consistent with
23this chapter.
AB133-ASA1-AA2, s. 2400qe 24Section 2400qe. 251.03 (4m) of the statutes is repealed and recreated to read:
AB133-ASA1-AA2,417,9
1251.03 (4m) Subsections (1) to (4) do not apply to a city, village or town that
2establishes a multiple municipal local health department under s. 251.02 (3m). In
3establishing a multiple municipal local health department as described under s.
4251.02 (3m), the relevant governing bodies shall agree on how many members of the
5local board of health are appointed by each governing body and how many of each
6governing body's appointees shall be members who are not elected officials or
7employes of the governing body. The members shall be appointed by the relevant
8governing bodies. A local board of health under this subsection shall elect a
9chairperson and clerk.
AB133-ASA1-AA2, s. 2400qf 10Section 2400qf. 251.04 (1) of the statutes is amended to read:
AB133-ASA1-AA2,417,1811 251.04 (1) A city or county board of health shall govern each local health
12department other than a local health department as authorized in s. 251.02 (3m) and
13a city or county board of health or a board of health for a local health department as
14authorized in s. 251.02 (3m) shall
assure the enforcement of state public health
15statutes and public health rules of the department as prescribed for a Level I local
16health department. A local board of health may contract or subcontract to provide
17public health services. The contractor's staff shall meet the appropriate
18qualifications for positions in a Level I local health department.
AB133-ASA1-AA2, s. 2400qg 19Section 2400qg. 251.04 (2) of the statutes is amended to read:
AB133-ASA1-AA2,417,2320 251.04 (2) A city or county board of health or a board of health for a local health
21department as authorized in s. 251.02 (3m)
shall assure that its local health
22department is a Level I, Level II or Level III local health department, as specified in
23s. 251.05 (1).
AB133-ASA1-AA2, s. 2400qh 24Section 2400qh. 251.04 (3) of the statutes is amended to read:
AB133-ASA1-AA2,418,5
1251.04 (3) A city or county board of health or a board of health for a local health
2department as authorized in s. 251.02 (3m)
may adopt those regulations, for its own
3guidance and for the governance of the local health department, that it considers
4necessary to protect and improve public health. The regulations may be no less
5stringent than, and may not conflict with, state statutes and rules of the department.
AB133-ASA1-AA2, s. 2400qi 6Section 2400qi. 251.06 (1) (a) 2. of the statutes is amended to read:
AB133-ASA1-AA2,418,137 251.06 (1) (a) 2. A local health officer of a village or town multiple municipal
8local
health department established under s. 251.02 (3m) shall be either a physician
9or a registered nurse. The local health officer shall be a voting member of the local
10board of health and shall take an oath of office. With respect to the levels of services
11of a Level I local health department, as specified in s. 251.05 (2) (a), the local health
12officer shall be authorized to act by and be directed by the county health officer of the
13county specified under s. 251.02 (3m).
AB133-ASA1-AA2, s. 2400qim 14Section 2400qim. 251.06 (2) (c) (intro.) of the statutes is amended to read:
AB133-ASA1-AA2,418,1715 251.06 (2) (c) (intro.) A local health officer of a multiple municipal local health
16department of a village or town established under s. 251.02 (3m) shall be one of the
17following:
AB133-ASA1-AA2, s. 2400qin 18Section 2400qin. 251.06 (2) (c) 1. of the statutes is amended to read:
AB133-ASA1-AA2,418,2019 251.06 (2) (c) 1. An employe of the multiple municipal local health department
20of the village or town.
AB133-ASA1-AA2, s. 2400qj 21Section 2400qj. 251.06 (4) (c) of the statutes is amended to read:
AB133-ASA1-AA2,418,2422 251.06 (4) (c) A local health officer of a village or town multiple municipal local
23health department established under s. 251.02 (3m) shall be appointed by the local
24board of health.
AB133-ASA1-AA2, s. 2400qk 25Section 2400qk. 251.12 of the statutes is amended to read:
AB133-ASA1-AA2,419,5
1251.12 City health department, how financed. The common council shall
2appropriate funds for the operation of a city health department that is established
3as specified in s. 251.02 (1) and (2) and for the operation of a multiple municipal local
4health department that is established under s. 251.02 (3m) by the governing body of
5a city in concert with the governing body of another city or a village or town
.
AB133-ASA1-AA2, s. 2400qL 6Section 2400qL. 251.125 of the statutes is amended to read:
AB133-ASA1-AA2,419,11 7251.125 Village health department, how financed. If a village health
8department is established under s. 251.02 (2) or (3m) or if a multiple municipal local
9health department is established under s. 251.01 (3m) by the governing body of a
10village in concert with the governing body of another village or a city or town
, the
11village board shall appropriate funds for the operation of the department.
AB133-ASA1-AA2, s. 2400qm 12Section 2400qm. 251.127 of the statutes is amended to read:
AB133-ASA1-AA2,419,17 13251.127 Town health department, how financed. If a town multiple
14municipal local
health department is established under s. 251.02 (3m) by the
15governing body of a town in concert with the governing body of another town or a city
16or village
, the town board shall appropriate funds for the operation of the
17department.".
AB133-ASA1-AA2,419,18 18915. Page 1211, line 18: after that line insert:
AB133-ASA1-AA2,419,20 19" Section 2400mf. 252.07 (1) of the statutes is renumbered 252.07 (1m) and
20amended to read:
AB133-ASA1-AA2,420,221 252.07 (1m) Tuberculosis is a communicable disease caused by mycobacterium
22tuberculosis and is
Infectious tuberculosis and suspect tuberculosis are subject to the
23reporting requirements specified in s. 252.05. Any laboratory that performs a test
24receives a specimen for tuberculosis testing shall report all positive results obtained

1by any appropriate procedure, including a procedure performed by an out-of-state
2laboratory,
to the local health officer and to the department.
Loading...
Loading...